Clinical Trial Update: N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart Failure [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether N-3 fatty acids can prevent atrial fibrillation in patients with acute heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Heart Failure
• Myocardial Infarction

Drugs mentioned

• N-3 Fatty Acids (omega-3 fatty acids)

Snippet

Sponsor: Osaka General Medical Center | Conditions: Acute Heart Failure, Acute Myocardial Infarction | Phase 4 | Status: UNKNOWN